Inconsistent and Specious Laws Criminalizing Addiction In my blog, “Is Suboxone the New Kleenex®?,” I attempted to clarify which opioids are used to treat addiction as well as pain, depending on their brand name or where they are being prescribed. A recent article in MEDPAGE TODAY titled “Suboxone Underused, Opioids Overused in Medicine” added some…
Read MoreCIPA EVYY Award Finalist I’m pleased and humbled to announce that my book, The Painful Truth: What Chronic Pain Is Really Like and Why It Matters to Each of Us, has been selected as a finalist in the 2016 CIPA EVVY Awards. It holds that spot in the Health/Diet/Fitness category. The Painful Truth is…
Read MoreConfusion About Suboxone There is an interesting recent article in MEDPAGE TODAY titled “Suboxone Underused, Opioids Overused in Medicine.” To me, that is an oxymoron. As I’ll explain, the title does make sense if you’re trying to communicate to the lay public, but it is an ambiguous and seemingly contradictory statement. Since there’s already way…
Read MoreNinety Percent of All Drug Addictions Start in the Teens “Ninety percent of all drug addictions start in the teens — and 75 percent of prescription opioid misuse begins when (mainly young) people get pills from friends, family or dealers — not doctors. Opioids are rarely the first drug people misuse.” This is an incredibly…
Read MorePresident Obama stands ready to sign the Comprehensive Addiction and Recovery Act (CARA). This bill will make available more treatments for opioid addiction and is intended to deter inappropriate prescribing of prescription opioids. As a recent Washington Post article points out, critics of CARA fear that this legislation could “cause prescription opioid users to switch…
Read MoreWhat Is CARA (The Comprehensive Addiction and Recovery Act of 2016)? By now, you may have heard of the Comprehensive Addiction and Recovery Act (CARA) of 2016. Designed to establish “a comprehensive, coordinated, balanced strategy through enhanced grant programs that would expand prevention and education efforts while also promoting treatment and recovery,” the bill…
Read MoreI’m pleased to say that I’ve signed the White House Petition that was recently launched by the National Fibromyalgia & Chronic Pain Association (NFMCPA) with Consumer Pain Advocacy Task Force (CPATF). The petition asks the White House to implement and fund the National Pain Strategy (NPS) toward a better future for people with debilitating, life-altering…
Read MoreI was troubled to see a recent story in the online publication, Counterpunch. It starts off by declaring the root cause of the opioid crisis is Pharma’s contribution to professional societies for “educational” programs. Counterpunch reports that the funding was provided to advocate for “more aggressive identification and treatment of pain.” Ironically, the tag line…
Read MoreAccording to a Baltimore Sun article, Dr. Mary Lynn McPherson, who teaches in the School of Pharmacy and specializes in hospice and end-of-life care, was removed from an FDA medical advisory panel along with three other doctors. The panel was organized by the National Academies of Sciences, Engineering, and Medicine. Grants and Funding Although the…
Read MoreIn a new press release posted by the Hazelden Betty Ford Institute for Recovery Advocacy, “The Hazelden Betty Ford Institute for Recovery Advocacy commends new steps taken by the American Medical Association (AMA) to help combat the national opioid crisis, and encourages continued action in the year ahead.” According to the Hazelden Betty Ford Institute, those…
Read More
Recent Comments